Search

Displaying results 341 - 350 of 6079 in total
  1. Drug

    Palivizumab

    go.drugbank.com/drugs/DB00110
    ApprovedInvestigational

    Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) ant...

    Categories: Antiinfectives for Systemic UseProducts: Synagis 100mg/ml solution for Injection, SYNAGIS SOLUTION FOR INJECTION 100MG/ML
  2. Drug

    Magnesium chloride

    go.drugbank.com/drugs/DB09407
    ApprovedInvestigational

    Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.

    Mixtures: Prismasol 2 mmol/l Kalium Lösung für Hämofiltration und Hämodialyse, Prismasol 4 mmol/l Kalium Lösung für Hämofiltration und HämodialyseProducts: Magnesium Chloride for Hemodialysis 5.15
  3. Drug

    Mebrofenin

    go.drugbank.com/drugs/DB15779
    Approved

    Products: Kit for the Preparation of Technetium Tc 99m Mebrofenin
  4. Drug

    Cephalexin

    go.drugbank.com/drugs/DB00567
    ApprovedInvestigationalVet approved

    Cephalexin is the first of the first generation cephalosporins. This antibiotic contains a beta lactam and a dihydrothiazide. Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthe...

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Ospexin 125 mg/5 ml - Granulat für orale Suspension, Ospexin 250 mg/5 ml - Granulat für orale Suspension
  5. Drug

    Faricimab

    go.drugbank.com/drugs/DB15303
    ApprovedInvestigational

    [L42305] In July 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended faricimab be granted marketing authorization for the treatment of neovascular age-related macular degeneration … [L40026] It received subsequent approval for the same indications in Canada in May 2022.

    Products: VABYSMO 6mg/0.05mL Solution for Intravitreal Injection
  6. Drug

    Urea C-13

    go.drugbank.com/drugs/DB09510
    ApprovedInvestigational

    It is currently used for the Urea Breath Test (UBT) and is available as a rapid diagnostic test (marketed as Pranactin-Citric) for the detection of Helicobacter pylori infections. … Exhaled breath samples can then be collected and measured for the presence of radioactivity.

    Products: Helicobacter Test Infai for Children Of The Age 3-11
  7. Drug

    Selenium

    go.drugbank.com/drugs/DB11135
    ApprovedInvestigationalVet approved

    Selenium is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species [FDA Label]

    Mixtures: For-2, For MenProducts: selenase 500 micrograms, solution for injection (50 micrograms/ml), selenase ® 100 micrograms, solution for injection (50 micrograms/ml)
  8. Drug

    Cetuximab

    go.drugbank.com/drugs/DB00002
    ApprovedInvestigational

    [A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis. … [A227963] Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic

    Products: ERBITUX 5MG/ML SOLUTION FOR INFUSION
  9. Drug

    Rocuronium

    go.drugbank.com/drugs/DB00728
    ApprovedInvestigational

    Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotra...

    Products: Rocuronium Kabi 10mg/ml Solution for Injection/Infusion, ROCURONIUM BROMIDE SOLUTION FOR INJECTION 10mg/ml
  10. Drug

    Galsulfase

    go.drugbank.com/drugs/DB01279
    ApprovedInvestigational

    The recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular … Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family

    Products: Naglazyme Concentrated Solution for Intravenous Infusion 1mg/1ml